Global and Regional Lung Cancer Surgery Market research

Lung Cancer Surgery Comprehensive Study by Type (Thoracotomy, Minimally Invasive Surgeries), Application (Hospital, Operating room, Outpatient clinic, Outpatient clinic) Players and Region - Global Market Outlook to 2030

Lung Cancer Surgery Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Lung Cancer Surgery
Lung cancer surgery is done for the patients in which cancer is caused by formation of tumor owing to uncontrolled growth of cells in the lungs tissues. Primary lung cancer is also known as carcinomas which occurs in the lungs whereas secondary lung cancer begins in other parts of the body. Rising incidences and prevalence of lung cancer demand an innovative and cost effective solution at large scale which provide immense growth opportunity for key players as well as for new entrants.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR7.1%


The market of solutions for Lung Cancer Surgery is expected to grow with rising demand for surgeries. Numerous companies are operating in the market to provide Lung Cancer Surgery for treatment of lung diseases. The market is highly fragmented with the presence of several market players. They are gaining attention owing to their innovative and novel portfolio. In addition, market profitability is attracting new entrant which is turn impacted on competitive rivalry. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Lung Cancer Surgery market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Accuray Incorporated [United States], Angiodynamics Inc. [United States], Ethicon Us [United States], Johnson & Johnson LLC [Russia], Intuitive Surgical Inc. [United States], Olympus Corporation [Japan], Teleflex Incorporated [United States], Ackermann Instrumente GmbH [Germany], Karl Storz GmbH [Germany], Scanlan International [United States] and Trokamed GmbH [Germany] are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Richard Wolf GmbH [Germany], Neomend Inc [United States], Siemens Healthineers [Germany], Biotronik [Germany], MicroPort Scientific [China] and Abbott Laboratories [United States].

Segmentation Overview
AMA Research has segmented the market of Global Lung Cancer Surgery market by Type (Thoracotomy and Minimally Invasive Surgeries), Application (Hospital, Operating room, Outpatient clinic and Outpatient clinic) and Region.



On the basis of geography, the market of Lung Cancer Surgery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Growing Research and Developments to Find Cost Effective Solution and Increasing Health Budget in Developing Countries

Market Growth Drivers:
Growing Geriatric Population, Rising Number of Lung Cancer Cases and Technical Advancement Lung Cancer Treatment Methods

Challenges:
Lack of Qualified Oncologist and Lack of Awareness About Advance Surgery Methods In Emerging Countries

Restraints:
High Cost of Lung Cancer Surgeries and Effective Alternative Treatment Methods

Opportunities:
Government Initiatives to Prevent and Treat Cancer and Growing Health Awareness and Disposable Income in Emerging Countries

Market Leaders and their expansionary development strategies
In February 2020, Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery has acquired privately held Orpheus Medical to deepen and expand its integrated informatics platform. With this acquisition, company has strengthen and expanded its existence portfolio.
United States' Food and Drug Administration approved Opdivo (nivolumab) for patients with metastatic small cell lung cancer (SCLC). This is the first immunotherapy treatment approved for SCLC and early approval was the result of positive results of a recent study.


Key Target Audience
Manufacturers of Surgical Robots and Lasers, Vendors and Distributors of Powered Surgical Instruments, Hospitals, Research Institutes Related to Cancer Studies, Venture Capitalists and Investors and Potential Investors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Thoracotomy
  • Minimally Invasive Surgeries
By Application
  • Hospital
  • Operating room
  • Outpatient clinic
  • Outpatient clinic
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population
      • 3.2.2. Rising Number of Lung Cancer Cases
      • 3.2.3. Technical Advancement Lung Cancer Treatment Methods
    • 3.3. Market Challenges
      • 3.3.1. Lack of Qualified Oncologist
      • 3.3.2. Lack of Awareness About Advance Surgery Methods In Emerging Countries
    • 3.4. Market Trends
      • 3.4.1. Growing Research and Developments to Find Cost Effective Solution
      • 3.4.2. Increasing Health Budget in Developing Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Lung Cancer Surgery, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Lung Cancer Surgery (Value)
      • 5.2.1. Global Lung Cancer Surgery by: Type (Value)
        • 5.2.1.1. Thoracotomy
        • 5.2.1.2. Minimally Invasive Surgeries
      • 5.2.2. Global Lung Cancer Surgery by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Operating room
        • 5.2.2.3. Outpatient clinic
        • 5.2.2.4. Outpatient clinic
      • 5.2.3. Global Lung Cancer Surgery Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Lung Cancer Surgery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Accuray Incorporated [United States]
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Angiodynamics Inc. [United States]
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ethicon Us [United States]
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson & Johnson LLC [Russia]
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Intuitive Surgical Inc. [United States]
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Olympus Corporation [Japan]
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Teleflex Incorporated [United States]
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ackermann Instrumente GmbH [Germany]
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Karl Storz GmbH [Germany]
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Scanlan International [United States]
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Trokamed GmbH [Germany]
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Lung Cancer Surgery Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Lung Cancer Surgery (Value)
      • 7.2.1. Global Lung Cancer Surgery by: Type (Value)
        • 7.2.1.1. Thoracotomy
        • 7.2.1.2. Minimally Invasive Surgeries
      • 7.2.2. Global Lung Cancer Surgery by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Operating room
        • 7.2.2.3. Outpatient clinic
        • 7.2.2.4. Outpatient clinic
      • 7.2.3. Global Lung Cancer Surgery Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Lung Cancer Surgery: by Type(USD Million)
  • Table 2. Lung Cancer Surgery Thoracotomy , by Region USD Million (2018-2023)
  • Table 3. Lung Cancer Surgery Minimally Invasive Surgeries , by Region USD Million (2018-2023)
  • Table 4. Lung Cancer Surgery: by Application(USD Million)
  • Table 5. Lung Cancer Surgery Hospital , by Region USD Million (2018-2023)
  • Table 6. Lung Cancer Surgery Operating room , by Region USD Million (2018-2023)
  • Table 7. Lung Cancer Surgery Outpatient clinic , by Region USD Million (2018-2023)
  • Table 8. Lung Cancer Surgery Outpatient clinic , by Region USD Million (2018-2023)
  • Table 9. South America Lung Cancer Surgery, by Country USD Million (2018-2023)
  • Table 10. South America Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 11. South America Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 12. Brazil Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 13. Brazil Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 14. Argentina Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 15. Argentina Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 16. Rest of South America Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 17. Rest of South America Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 18. Asia Pacific Lung Cancer Surgery, by Country USD Million (2018-2023)
  • Table 19. Asia Pacific Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 20. Asia Pacific Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 21. China Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 22. China Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 23. Japan Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 24. Japan Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 25. India Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 26. India Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 27. South Korea Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 28. South Korea Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 29. Taiwan Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 30. Taiwan Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 31. Australia Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 32. Australia Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 35. Europe Lung Cancer Surgery, by Country USD Million (2018-2023)
  • Table 36. Europe Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 37. Europe Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 38. Germany Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 39. Germany Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 40. France Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 41. France Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 42. Italy Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 43. Italy Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 44. United Kingdom Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 45. United Kingdom Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 46. Netherlands Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 47. Netherlands Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 48. Rest of Europe Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 49. Rest of Europe Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 50. MEA Lung Cancer Surgery, by Country USD Million (2018-2023)
  • Table 51. MEA Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 52. MEA Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 53. Middle East Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 54. Middle East Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 55. Africa Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 56. Africa Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 57. North America Lung Cancer Surgery, by Country USD Million (2018-2023)
  • Table 58. North America Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 59. North America Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 60. United States Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 61. United States Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 62. Canada Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 63. Canada Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 64. Mexico Lung Cancer Surgery, by Type USD Million (2018-2023)
  • Table 65. Mexico Lung Cancer Surgery, by Application USD Million (2018-2023)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Lung Cancer Surgery: by Type(USD Million)
  • Table 78. Lung Cancer Surgery Thoracotomy , by Region USD Million (2025-2030)
  • Table 79. Lung Cancer Surgery Minimally Invasive Surgeries , by Region USD Million (2025-2030)
  • Table 80. Lung Cancer Surgery: by Application(USD Million)
  • Table 81. Lung Cancer Surgery Hospital , by Region USD Million (2025-2030)
  • Table 82. Lung Cancer Surgery Operating room , by Region USD Million (2025-2030)
  • Table 83. Lung Cancer Surgery Outpatient clinic , by Region USD Million (2025-2030)
  • Table 84. Lung Cancer Surgery Outpatient clinic , by Region USD Million (2025-2030)
  • Table 85. South America Lung Cancer Surgery, by Country USD Million (2025-2030)
  • Table 86. South America Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 87. South America Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 88. Brazil Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 89. Brazil Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 90. Argentina Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 91. Argentina Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 92. Rest of South America Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 93. Rest of South America Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 94. Asia Pacific Lung Cancer Surgery, by Country USD Million (2025-2030)
  • Table 95. Asia Pacific Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 96. Asia Pacific Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 97. China Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 98. China Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 99. Japan Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 100. Japan Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 101. India Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 102. India Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 103. South Korea Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 104. South Korea Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 105. Taiwan Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 106. Taiwan Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 107. Australia Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 108. Australia Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 109. Rest of Asia-Pacific Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 110. Rest of Asia-Pacific Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 111. Europe Lung Cancer Surgery, by Country USD Million (2025-2030)
  • Table 112. Europe Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 113. Europe Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 114. Germany Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 115. Germany Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 116. France Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 117. France Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 118. Italy Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 119. Italy Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 120. United Kingdom Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 121. United Kingdom Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 122. Netherlands Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 123. Netherlands Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 124. Rest of Europe Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 125. Rest of Europe Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 126. MEA Lung Cancer Surgery, by Country USD Million (2025-2030)
  • Table 127. MEA Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 128. MEA Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 129. Middle East Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 130. Middle East Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 131. Africa Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 132. Africa Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 133. North America Lung Cancer Surgery, by Country USD Million (2025-2030)
  • Table 134. North America Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 135. North America Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 136. United States Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 137. United States Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 138. Canada Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 139. Canada Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 140. Mexico Lung Cancer Surgery, by Type USD Million (2025-2030)
  • Table 141. Mexico Lung Cancer Surgery, by Application USD Million (2025-2030)
  • Table 142. Research Programs/Design for This Report
  • Table 143. Key Data Information from Secondary Sources
  • Table 144. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Lung Cancer Surgery: by Type USD Million (2018-2023)
  • Figure 5. Global Lung Cancer Surgery: by Application USD Million (2018-2023)
  • Figure 6. South America Lung Cancer Surgery Share (%), by Country
  • Figure 7. Asia Pacific Lung Cancer Surgery Share (%), by Country
  • Figure 8. Europe Lung Cancer Surgery Share (%), by Country
  • Figure 9. MEA Lung Cancer Surgery Share (%), by Country
  • Figure 10. North America Lung Cancer Surgery Share (%), by Country
  • Figure 11. Global Lung Cancer Surgery share by Players 2023 (%)
  • Figure 12. Global Lung Cancer Surgery share by Players (Top 3) 2023(%)
  • Figure 13. Global Lung Cancer Surgery share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Accuray Incorporated [United States] Revenue, Net Income and Gross profit
  • Figure 16. Accuray Incorporated [United States] Revenue: by Geography 2023
  • Figure 17. Angiodynamics Inc. [United States] Revenue, Net Income and Gross profit
  • Figure 18. Angiodynamics Inc. [United States] Revenue: by Geography 2023
  • Figure 19. Ethicon Us [United States] Revenue, Net Income and Gross profit
  • Figure 20. Ethicon Us [United States] Revenue: by Geography 2023
  • Figure 21. Johnson & Johnson LLC [Russia] Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson LLC [Russia] Revenue: by Geography 2023
  • Figure 23. Intuitive Surgical Inc. [United States] Revenue, Net Income and Gross profit
  • Figure 24. Intuitive Surgical Inc. [United States] Revenue: by Geography 2023
  • Figure 25. Olympus Corporation [Japan] Revenue, Net Income and Gross profit
  • Figure 26. Olympus Corporation [Japan] Revenue: by Geography 2023
  • Figure 27. Teleflex Incorporated [United States] Revenue, Net Income and Gross profit
  • Figure 28. Teleflex Incorporated [United States] Revenue: by Geography 2023
  • Figure 29. Ackermann Instrumente GmbH [Germany] Revenue, Net Income and Gross profit
  • Figure 30. Ackermann Instrumente GmbH [Germany] Revenue: by Geography 2023
  • Figure 31. Karl Storz GmbH [Germany] Revenue, Net Income and Gross profit
  • Figure 32. Karl Storz GmbH [Germany] Revenue: by Geography 2023
  • Figure 33. Scanlan International [United States] Revenue, Net Income and Gross profit
  • Figure 34. Scanlan International [United States] Revenue: by Geography 2023
  • Figure 35. Trokamed GmbH [Germany] Revenue, Net Income and Gross profit
  • Figure 36. Trokamed GmbH [Germany] Revenue: by Geography 2023
  • Figure 37. Global Lung Cancer Surgery: by Type USD Million (2025-2030)
  • Figure 38. Global Lung Cancer Surgery: by Application USD Million (2025-2030)
  • Figure 39. South America Lung Cancer Surgery Share (%), by Country
  • Figure 40. Asia Pacific Lung Cancer Surgery Share (%), by Country
  • Figure 41. Europe Lung Cancer Surgery Share (%), by Country
  • Figure 42. MEA Lung Cancer Surgery Share (%), by Country
  • Figure 43. North America Lung Cancer Surgery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Accuray Incorporated [United States]
  • Angiodynamics Inc. [United States]
  • Ethicon Us [United States]
  • Johnson & Johnson LLC [Russia]
  • Intuitive Surgical Inc. [United States]
  • Olympus Corporation [Japan]
  • Teleflex Incorporated [United States]
  • Ackermann Instrumente GmbH [Germany]
  • Karl Storz GmbH [Germany]
  • Scanlan International [United States]
  • Trokamed GmbH [Germany]
Additional players considered in the study are as follows:
Richard Wolf GmbH [Germany] , Neomend Inc [United States] , Siemens Healthineers [Germany] , Biotronik [Germany] , MicroPort Scientific [China] , Abbott Laboratories [United States]
Select User Access Type

Key Highlights of Report


Apr 2024 210 Pages 55 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Lung Cancer Surgery Market research Quantitative research analysis
Global and Regional Lung Cancer Surgery Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Accuray Incorporated [United States], Angiodynamics Inc. [United States], Ethicon Us [United States], Johnson & Johnson LLC [Russia], Intuitive Surgical Inc. [United States], Olympus Corporation [Japan], Teleflex Incorporated [United States], Ackermann Instrumente GmbH [Germany], Karl Storz GmbH [Germany], Scanlan International [United States] and Trokamed GmbH [Germany] etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Research and Developments to Find Cost Effective Solution " is seen as one of major influencing trends for Lung Cancer Surgery Market during projected period 2023-2030.
The Lung Cancer Surgery market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global and Regional Lung Cancer Surgery Market research Report?

Have a Query? Click Here

Other Related Reports

Artificial Teeth Comprehensive Study by Type (All-ceramic, Metal-ceramic, All-metal), Application (Hospitals, Dental Clinics), Denture type (Partial denture, Complete denture, Overdenture, Immediate ...
$ 3650
Medical Compression Garments Comprehensive Study by Type (Upper Compression Garments, Lower Compression Garments), Application (Varicose Vein, Wound Care, Burns, Oncology, Other Indications), Gender ...
$ 3500
Blood Group Typing Comprehensive Study by Application (Hospitals, Clinical Laboratories, Blood Banks, Other End Users), Technique (PCR-Based, Microarray Techniques, Assay-Based Techniques, Massively ...
$ 3750
Cardiovascular Ultrasound Comprehensive Study by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, Other Echocardiograms), Application (Hospitals, Cardiology ...
$ 3650
Consumer Healthcare Comprehensive Study by Type (OTC Pharmaceuticals, Dietary Supplements, Herbal Products), Distribution Channel (E-Commerce, Retail Stores, Convenience Stores, Pharmacy Stores, Supe...
$ 3350
Foam Dressings Comprehensive Study by Type (Foam Dressings With Adhesive Border, Foam Dressings With Silicone Border), Application (Hospitals, Clinics, Homecare, Other), Pore Size (Small, Medium, Lar...
$ 3500